hers hims semaglutide Novo is suing & to halt obesity drug copycats Novo Nordisk halts Wegovy sales

Northwestern Medicine researchers called these rates alarming.[breakthroughsforphysicians.nm +3] When patients stop, weight rebounds fast ~60% of lost weight returns within 12 months of discontinuation

Understanding your options and what to expect Delivery timing and how the process works General questions before you decide Reported Mental Health Side Effects and Evidence The relationship between GLP-1 receptor agonists and mental health has received increased scrutiny following post-marketing surveillance reports

widely cited timeframes such as 28 days are unverified and should not be treated as clinical guidance

Before initiating GLP-1 receptor agonist therapy, clinicians should conduct a comprehensive personal and family history assessment focusing specifically on thyroid disorders and endocrine neoplasia syndromes

Treatment discussion If appropriate, semaglutide options such as Ozempic, Wegovy, or compounded semaglutide may be discussed with structured guidance